SPI
|
17 351,42
|
-9,16
|
-0,05 %
|
Analysen zu SPI-Werten
| 04.04.24 | Novartis Buy | UBS AG | |
| 04.04.24 | Nestlé Underperform | Jefferies & Company Inc. | |
| 04.04.24 | Richemont Buy | Jefferies & Company Inc. | |
| 04.04.24 | UBS Outperform | RBC Capital Markets | |
| 04.04.24 | ams-OSRAM Buy | Jefferies & Company Inc. | |
| 03.04.24 | Swiss Re Sell | UBS AG | |
| 03.04.24 | Givaudan Sell | UBS AG | |
| 03.04.24 | Swiss Re Hold | Jefferies & Company Inc. | |
| 03.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.04.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 02.04.24 | Givaudan Underweight | Barclays Capital | |
| 02.04.24 | Richemont Overweight | Barclays Capital | |
| 02.04.24 | DocMorris Sell | UBS AG | |
| 02.04.24 | ams-OSRAM Equal Weight | Barclays Capital | |
| 02.04.24 | Richemont Buy | UBS AG | |
| 02.04.24 | ABB Hold | Deutsche Bank AG | |
| 02.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 28.03.24 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 28.03.24 | Richemont Buy | Jefferies & Company Inc. | |
| 28.03.24 | UBS Outperform | RBC Capital Markets | |
| 28.03.24 | Richemont Sector Perform | RBC Capital Markets | |
| 28.03.24 | Novartis Underweight | Barclays Capital | |
| 27.03.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 27.03.24 | Richemont Overweight | JP Morgan Chase & Co. | |
| 26.03.24 | DocMorris Add | Baader Bank | |
| 26.03.24 | Nestlé Buy | Deutsche Bank AG | |
| 26.03.24 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 25.03.24 | Nestlé Underperform | Jefferies & Company Inc. | |
| 25.03.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.03.24 | UBS Outperform | RBC Capital Markets | |
| 22.03.24 | ams-OSRAM kaufen | Baader Bank | |
| 22.03.24 | Roche Sell | Deutsche Bank AG | |
| 22.03.24 | Novartis Buy | Deutsche Bank AG | |
| 22.03.24 | ABB Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.03.24 | DocMorris Buy | Deutsche Bank AG | |
| 22.03.24 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 22.03.24 | DocMorris Buy | Warburg Research | |
| 21.03.24 | Nestlé Buy | UBS AG | |
| 21.03.24 | DocMorris Buy | Warburg Research | |
| 21.03.24 | Roche Sell | Deutsche Bank AG |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.